ECP for Optic Atrophy

EECP has been used in ischemic disease such as retinal arterial obstruction, ischemic optic neuropathy and optic atrophy in the Department of Ophthalmology, the First Affiliated Hospital of Sun Yat-Sen University, and has been proven to have a significant curative effect. Optic nerves are the nerve endings of cerebrum. During the process of optic atrophy, some optic nerve fibers are reversible, and their function improves with prompt recovery of blood supply. EECP can oppress limbs during the relaxation period, increase the blood flow of carotid and vertebral arteries, as well as increase the volume of blood flow of the ophthalmic artery. EECP simultaneously increases the perfusion pressure of posterior ciliary arteries and blood supply of the optic nerve, decreases ischemia and the poor supply of oxygen in the optic nerve. As a result, EECP gradually improves the visual function, and significantly improves the visual acuity and field of vision of patients.

Product Dimensions and Weight （P-ECP/TI）

Physical dimensions: length × width × height = 2070mm × 1120mm × 1100mm

Net weight: 220kg

Gross weight: 300kg

TI with touch screen